share_log

Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%), etc.

SEC ·  Nov 22, 2024 05:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more